News & Updates
Filter by Specialty:
Oral tebipenem pivoxil hydrobromide works against complicated UTI, acute pyelonephritis
Oral tebipenem pivoxil hydrobromide appears to be as good as intravenous ertapenem in the treatment of patients with complicated urinary tract infection (UTI) and acute pyelonephritis, with the two having a similar safety profile, according to data from a phase III study.
Oral tebipenem pivoxil hydrobromide works against complicated UTI, acute pyelonephritis
16 May 2022
Long-term aspirin use lowers HCC risk in chronic HBV patients
Use of aspirin in the long term appears to markedly reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV), a study has shown.
Long-term aspirin use lowers HCC risk in chronic HBV patients
14 May 2022
No apparent link between COVID-19 vax and cerebrovascular outcomes
Several studies presented at AAN 2022 have revealed a lack of association between COVID-19 vaccination and negative cerebrovascular outcomes.
No apparent link between COVID-19 vax and cerebrovascular outcomes
13 May 2022
Early remdesivir shields transplant recipients against life-threatening COVID-19
In solid organ transplant recipients with moderate symptoms of SARS-CoV-2 infection, early administration of a 3-day remdesivir course appears to effectively prevent COVID-19-related hospitalization as well as the clinical worsening of those who are hospitalized, according to a study.
Early remdesivir shields transplant recipients against life-threatening COVID-19
12 May 2022
COVID-19 no deterrent for breastfeeding
While mothers largely feel uncertain about the safety of breastfeeding during COVID-19, the pandemic did not seem to significantly discourage the practice, according to a study presented at the 2022 Annual Clinical & Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG 2022).
